CNN2P10

Across TCGA pan-cancer cohorts, CNN2P10 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated CNN2P10 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher CNN2P10 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CNN2P10 expression acts as an unfavorable survival marker.

MESO, KIRC, and LIHC are the cancer types where CNN2P10 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.100	0.590	<.001	108	view →
KIRC	OS	Tertile	All	0.488	0.660	<.001	102	view →
LIHC	OS	Tertile	All	0.230	0.526	<.001	45	view →
THCA	DFS	Tertile	All	0.407	0.825	<.001	27	view →
READ	OS	Tertile	III,IV	0.334	0.752	.009	27	view →
COAD	DFS	Tertile	IV	0.035	0.501	<.001	18	view →
STAD	DFS	Quartile	III,IV	0.353	0.651	.002	12	view →
PRAD	OS	Tertile	All	0.970	0.995	.035	12	view →
BLCA	OS	Tertile	IV	0.214	0.484	.049	9	view →
ACC	DFS	Tertile	All	0.195	0.748	.003	9	view →
SARC	DFS	Tertile	All	0.153	0.360	.024	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

CNN2P10–MESO (OS)

Open the MESO breakdown →